岳娅乐，博士，副教授，硕士生导师。担任河南省肿瘤药理学会委员，河南省优秀青年基金获得者。师从聂广军研究员，2022年毕业于郑州大学基础医学院，获医学博士学位。2022年8月入职郑州大学基础医学院药理学系，同期加入郑州大学中原纳米酶实验室，研究方向聚焦于工程菌的设计及肿瘤免疫治疗研究，以第一或通讯作者身份在Nature Biomedical Engineering, Nature Communications, Advanced Functional Materials, Advanced Materials等期刊发表多篇SCI学术论文；主持国家自然科学基金1项，主持博士后特别资助1项，获得河南省博士后创新人才项目1项，参编教材1部。

邮箱：yueyl@zzu.edu.cn

主要发表文章

1、Yue Y#, Xin Q#, Zhu Y, Zhu D, Zhang B, Yan X*, Jiang B*. Probiotic-based oral vaccine mucosal delivery system enabling genetically encoded dual-antigen arrays. Nat Commun. 2025 Nov 22;16(1):11540. （IF=15.7）

2、B. Zhang#, Y. Yuan#, Q. Xin, S. Wang, Y. Feng, X. Yan, T. Fan#, B. Jiang#, Y. Yue#, Self-Oxygenated Biomimetic Nanozyme for Tumor Catalytic Immunotherapy. Adv. Funct. Mater. 2024, 35, 2411103. （IF=19）

3、Qi Y, Shen J, Liu C, Du A, Chen M, Meng X, Wang H, Zhang, S, Zhang L, Li Z, Li Y, Yue Y#, Min# H#. Modularly designed peptide-based nanomedicine inhibits angiogenesis to enhance chemotherapy for post-surgical recurrence of esophageal squamous cell carcinomas [J]. Nano Research, 2023, 16(5): 7347-54. （IF=9）

4、Yue Y, Xu J, Li Y, Cheng K, Feng Q, Ma X, Ma N, Zhang T, Wang X, Zhao X*, Nie G*. Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria. Nat Biomed Eng. 2022 Jul;6(7):898-909. （IF=26.7）

5、Li Y#, Ma X#, Yue Y#, Zhang K, Cheng K, Feng Q, Ma N, Liang J, Zhang T, Zhang L, Chen Z, Wang X, Ren L*, Zhao X*, Nie G*. Rapid Surface Display of mRNA Antigens by Bacteria-Derived Outer Membrane Vesicles for a Personalized Tumor Vaccine. Adv Mater. 2022 May;34(20):e2109984. （IF=26.8）

6、Yue Y, Li F, Li Y, Wang Y, Guo X, Cheng Z, Li N, Ma X, Nie G*, Zhao X*. Biomimetic Nanoparticles Carrying a Repolarization Agent of Tumor-Associated Macrophages for Remodeling of the Inflammatory Microenvironment Following Photothermal Therapy. ACS Nano. 2021 Sep 28;15(9):15166-15179. （IF=16.1）